Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Accumulated Depreciation & Amortization (2016 - 2025)

Vycor Medical has reported Accumulated Depreciation & Amortization over the past 15 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 5.22% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 5.22% year-over-year, with the annual reading at $1.3 million for FY2025, 5.22% up from the prior year.
  • Accumulated Depreciation & Amortization was $1.3 million for Q4 2025 at Vycor Medical, up from $1.2 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $1.3 million in Q4 2025 and troughed at $1.0 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $1.1 million (2023), against an average of $1.1 million.
  • Year-over-year, Accumulated Depreciation & Amortization rose 6.0% in 2022 and then increased 5.22% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.0 million in 2021, then rose by 6.0% to $1.1 million in 2022, then increased by 5.6% to $1.1 million in 2023, then increased by 5.58% to $1.2 million in 2024, then increased by 5.22% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Accumulated Depreciation & Amortization are $1.3 million (Q4 2025), $1.2 million (Q4 2024), and $1.1 million (Q4 2023).